Zydus Healthcare Arm Acquires Six Drugs from United States Drug Maker MSD

In a strategic acquisition, Pharma major Zydus Cadila announced that its healthcare arm had acquired six brands from United States drug maker MSD and its subsidiaries for an undisclosed amount.

The Mumbai-based MSD is the Indian subsidiary of the American global pharmaceutical multinational Merck & Co, which is Merck Sharp & Dohme (MSD) outside the US and Canada.

Zydus Cadila Receives FDA Approval for Marketing Pioglitazone in US
Zydus Cadila revealed that it has received the final approval from the USFDA to market its anti-diabetic drug.

‘Zydus' strategic acquisition of six brands from United States drug maker MSD will strengthen its' portfolio in therapeutic segments.’

Tweet it Now

The brands are Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten in the men's health, women's health, wound management and cardiovascular therapy segments.

"The deal includes transfer of distribution and commercial rights and assignment of trademarks of the six brands to Zydus Healthcare Ltd in India," said the city-based company in a statement here.

MSD's other Indian arm - Organon Ltd also transferred the distribution and commercial rights for Deca-Durabolin and Durabolin to Zydus for Nepal.

Zydus Hospitals to Set Up Hospital Chain in Ahmedabad With Rs.1,000 crore Investment
The new hospital will treat critical surgical and therapeutic areas like organ transplant, pancreatic stone removal, neurological surgery for stroke.

"MSD's brands are a perfect addition and complement our core business with their strong equity. We look at this as an opportunity to strengthen our offerings to create value and growth," said Zydus Healthcare Chairman Sharvil Patel.

The acquisition will strengthen Zydus' portfolio in therapeutic segments, as Deca-Durabolin and Durabolin are prescribed drugs for treating osteoporosis, muscle wasting and management of negative nitrogen balance.

Avoid Buying Medicines from Online Pharmacies, Only 3% of Them are Safe and Legal
When it comes to purchasing medicine online, the convenience does not outweigh the risks, revealed researchers.

Sustanon is an injectable testosterone replacement therapy for men, while Multiload is an intra uterine device or contraceptive for women.

Axeten is an anti-hypertensive drug and Sicastat is used for healing wounds.

Indian Pharma Industry Has Enormous Opportunities To Discover New Drugs: Sun Pharma
Pharmaceutical companies are setting up labs abroad due to lack of expertise in India, so the core areas such as clinical development and research capabilities should be strengthened.

Source-IANS